Drug Profile
Lactoferricin B
Latest Information Update: 21 Feb 2002
Price :
$50
*
At a glance
- Originator Morinaga Milk Industry Company
- Class Anti-infectives; Iron binding proteins
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Toxoplasmosis
Most Recent Events
- 21 Feb 2002 No-Development-Reported for Mycoses in Japan (Unknown route)
- 13 Nov 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 13 Nov 2001 No-Development-Reported for Toxoplasmosis in Japan (Unknown route)